Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 202 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 52563 |
| 628 | 2 | SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR | 14172 |
| 320 | 1 | DPP 4 INHIBITOR//EXENATIDE//LIRAGLUTIDE | 3688 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | DPP 4 INHIBITOR | authKW | 1804628 | 8% | 68% | 309 |
| 2 | EXENATIDE | authKW | 1701577 | 9% | 63% | 314 |
| 3 | LIRAGLUTIDE | authKW | 1643293 | 9% | 60% | 319 |
| 4 | DIPEPTIDYL PEPTIDASE 4 INHIBITOR | authKW | 1455103 | 7% | 71% | 241 |
| 5 | SITAGLIPTIN | authKW | 1386383 | 8% | 58% | 282 |
| 6 | VILDAGLIPTIN | authKW | 1086121 | 5% | 68% | 188 |
| 7 | GLP 1 RECEPTOR AGONIST | authKW | 1047685 | 4% | 78% | 157 |
| 8 | INCRETIN | authKW | 928106 | 8% | 35% | 311 |
| 9 | LINAGLIPTIN | authKW | 836706 | 3% | 79% | 124 |
| 10 | SAXAGLIPTIN | authKW | 781761 | 3% | 76% | 121 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 62538 | 50% | 0% | 1836 |
| 2 | Pharmacology & Pharmacy | 4679 | 22% | 0% | 828 |
| 3 | Medicine, General & Internal | 2522 | 13% | 0% | 494 |
| 4 | Cardiac & Cardiovascular System | 1301 | 9% | 0% | 316 |
| 5 | Medicine, Research & Experimental | 822 | 7% | 0% | 249 |
| 6 | Peripheral Vascular Diseases | 407 | 4% | 0% | 141 |
| 7 | Primary Health Care | 365 | 1% | 0% | 40 |
| 8 | Toxicology | 72 | 2% | 0% | 79 |
| 9 | Physiology | 42 | 2% | 0% | 82 |
| 10 | Health Care Sciences & Services | 38 | 1% | 0% | 42 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | THER EUT AREA METAB | 94638 | 0% | 92% | 12 |
| 2 | LILLY DIABET | 91124 | 0% | 67% | 16 |
| 3 | DIABET METAB TRANSLAT MED UNIT | 57425 | 0% | 61% | 11 |
| 4 | DIABET ENDOCRINOL METAB RHEUMATOL | 52330 | 0% | 88% | 7 |
| 5 | DIABET NUTR METAB DISORDERS | 39128 | 1% | 17% | 27 |
| 6 | DIABET AGCY | 39014 | 1% | 24% | 19 |
| 7 | DIABET | 38332 | 6% | 2% | 211 |
| 8 | STUDY GRP DIABET COMM | 34176 | 0% | 100% | 4 |
| 9 | SECT GERIATR CARDIOL MED | 28770 | 0% | 42% | 8 |
| 10 | CIC INSERM ILCV | 25632 | 0% | 100% | 3 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | DIABETES OBESITY & METABOLISM | 500732 | 10% | 16% | 370 |
| 2 | DIABETES THERAPY | 162610 | 2% | 28% | 69 |
| 3 | JOURNAL OF DIABETES INVESTIGATION | 50260 | 2% | 10% | 62 |
| 4 | CARDIOVASCULAR DIABETOLOGY | 48718 | 2% | 7% | 87 |
| 5 | DIABETES CARE | 24891 | 5% | 2% | 184 |
| 6 | DIABETOLOGIE UND STOFFWECHSEL | 18368 | 1% | 9% | 25 |
| 7 | ENDOCRINE PRACTICE | 12443 | 1% | 4% | 41 |
| 8 | JOURNAL OF DIABETES | 12258 | 1% | 5% | 27 |
| 9 | CURRENT MEDICAL RESEARCH AND OPINION | 10337 | 2% | 2% | 75 |
| 10 | DIABETES & VASCULAR DISEASE RESEARCH | 10252 | 1% | 5% | 23 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | DPP 4 INHIBITOR | 1804628 | 8% | 68% | 309 | Search DPP+4+INHIBITOR | Search DPP+4+INHIBITOR |
| 2 | EXENATIDE | 1701577 | 9% | 63% | 314 | Search EXENATIDE | Search EXENATIDE |
| 3 | LIRAGLUTIDE | 1643293 | 9% | 60% | 319 | Search LIRAGLUTIDE | Search LIRAGLUTIDE |
| 4 | DIPEPTIDYL PEPTIDASE 4 INHIBITOR | 1455103 | 7% | 71% | 241 | Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR | Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR |
| 5 | SITAGLIPTIN | 1386383 | 8% | 58% | 282 | Search SITAGLIPTIN | Search SITAGLIPTIN |
| 6 | VILDAGLIPTIN | 1086121 | 5% | 68% | 188 | Search VILDAGLIPTIN | Search VILDAGLIPTIN |
| 7 | GLP 1 RECEPTOR AGONIST | 1047685 | 4% | 78% | 157 | Search GLP+1+RECEPTOR+AGONIST | Search GLP+1+RECEPTOR+AGONIST |
| 8 | INCRETIN | 928106 | 8% | 35% | 311 | Search INCRETIN | Search INCRETIN |
| 9 | LINAGLIPTIN | 836706 | 3% | 79% | 124 | Search LINAGLIPTIN | Search LINAGLIPTIN |
| 10 | SAXAGLIPTIN | 781761 | 3% | 76% | 121 | Search SAXAGLIPTIN | Search SAXAGLIPTIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |